Modulation of Growth Factor Action by the Extracellular Matrix

REFERENCES

• Massague J., Pandiella A. Membrane-anchored growth factors. Annu. Rev. Biochem. 1993; 62: 515–541
   PubMed Web of Science ®Google Scholar
• Singh A.B., Harris R.C. Autocrine, paracrine and juxtacrine signaling by EGFR ligands. Cell Signal. 2005; 17: 1183–1193
   PubMed Web of Science ®Google Scholar
• Schlessinger J., Lax I., Lemmon M. Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors?. Cell 1995; 83: 357–360
   PubMed Web of Science ®Google Scholar
• Heldin C.H. Dimerization of cell surface receptors in signal transduction. Cell 1995; 80: 213–223
   PubMed Web of Science ®Google Scholar
• Weiss F.U., Daub H., Ullrich A. Novel mechanisms of RTK signal generation. Curr. Opin. Genet, Dev. 1997; 7: 80–86
   PubMed Web of Science ®Google Scholar
• Schlessinger J., Lemmon M.A., Lax I., Lemmon M., Ozcan F., Klein P., Kemp L.E., Mulloy B., Gherardi E., Zioncheck T.F., Richardson L., Liu J., Chang L., King K.L., Bennett G.L., Fugedi P., Chamow S.M., Schwall R.H., Stack R.J., Chang L.Y., Godowski P.J., Kahn D.W., Hillan K.J., Bauer K.D., Spivak-Kroizman T., Dikic I., Ladbury J.E., Pinchasi D., Huang J., Jaye M., Crumley G. SH2 and PTB domains in tyrosine kinase signaling. SH2 and PTB domains in tyrosine kinase signaling. Sci. STKE 2003; 2003: RE12
   PubMedGoogle Scholar
• Manning G., Whyte D.B., Martinez R., Hunter T., Sudarsanam S. The protein kinase complement of the human genome. Science 2002; 298: 1912–1934
   PubMed Web of Science ®Google Scholar
• Lemmon M.A., Schlessinger J. Transmembrane signaling by receptor oligomerization. Methods Mol. Biol. 1998; 84: 49–71
   PubMedGoogle Scholar
• Hubbard S.R., Miller W.T. Receptor tyrosine kinases: mechanisms of activation and signaling. Curr. Opin. Cell Biol. 2007; 19: 117–123
   PubMed Web of Science ®Google Scholar
• Pawson T. Protein modules and signalling networks. Nature 1995; 373: 573–580
   PubMed Web of Science ®Google Scholar
• Derynck R., Feng X.H. TGF-beta receptor signaling. Biochim. Biophys. Acta 1997; F105: 1333–150
   Google Scholar
• Xu L. Regulation of Smad activities. Biochim. Biophys. Acta 2006; 1759: 503–513
   PubMed Web of Science ®Google Scholar
• Taipale J., Keski-Oja J. Growth factors in the extracellular matrix. FASEB J. 1997; 11: 51–59
   PubMed Web of Science ®Google Scholar
• Macri L., Silverstein D., Clark R.A.F. Growth factor binding to the pericellular matrix and its importance in tissue engineering. Adv. Drug Del. Rev. 2007; 59: 1366–1381
   PubMed Web of Science ®Google Scholar
• Robinson C.J., Stringer S.E. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J. Cell Sci. 2001; 114: 853–865
   PubMed Web of Science ®Google Scholar
• Springer M.L., Banfi A., Ye J., von Degenfeld G., Kraft P.E., Saini S.A., Kapasi N.K., Blau H.M. Localization of vascular response to VEGF is not dependent on heparin binding. FASEB J. 2007; 21: 2074–2085
   PubMed Web of Science ®Google Scholar
• Rahimi N. VEGFR-1 and VEGFR-2: two non-identical twins with a unique physiognomy. Front. Biosci. 2006; 11: 818–829
   PubMed Web of Science ®Google Scholar
• Powers C.J., McLeskey S.W., Wellstein A. Fibroblast growth factors, their receptors and signaling. Endocr. Relat. Cancer 2000; 7: 165–197
   PubMed Web of Science ®Google Scholar
• Harmer N.J. Insights into the role of heparan sulphate in fibroblast growth factor signalling. Biochem. Soc. Trans. 2006; 34: 442–445
   PubMed Web of Science ®Google Scholar
• Johnson D.E., Williams L.T. Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res. 1993; 60: 1–41
   PubMed Web of Science ®Google Scholar
• Miki T., Bottaro D., Fleming T., Smith C., Burgess W., Chan A., Aaronson S. Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. PNAS 1992; 89: 246–250
   PubMed Web of Science ®Google Scholar
• Abuharbeid S., Czubayko F., Aigner A. The fibroblast growth factor-binding protein FGF-BP. Int. J. Biochem. Cell Biol. 2006; 38: 1463–1468
   PubMed Web of Science ®Google Scholar
• Eswarakumar V.P., Lax I., Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 2005; 16: 139–149
   PubMed Web of Science ®Google Scholar
• Falls D.L. Neuregulins: functions, forms, and signaling strategies. Exp. Cell Res. 2003; 284: 14–30
   PubMed Web of Science ®Google Scholar
• Singh A.B., Sugimoto K., Harris R.C. Juxtacrine activation of EGFR by membrane-anchored HB-EGF protects epithelial cells from anoikis while maintaining an epithelial phenotype. J. Biol. Chem. 2007; 282: 32890–32901
   PubMed Web of Science ®Google Scholar
• Nishi E., Klagsbrun M. Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is a mediator of multiple physiological and pathological pathways. Growth Factors 2004; 22: 253–260
   PubMed Web of Science ®Google Scholar
• Bublil E.M., Yarden Y. The EGF receptor family: spearheading a merger of signaling and therapeutics. Curr. Opin. Cell Biol. 2007; 19: 124–134
   PubMed Web of Science ®Google Scholar
• Heldin C.H., Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 1999; 79: 1283–1316
   PubMed Web of Science ®Google Scholar
• Kelly J.L., Sanchez A., Brown G.S., Chesterman C.N., Sleigh M.J. Accumulation of PDGF B and cell-binding forms of PDGF A in the extracellular matrix. J. Cell Biol. 1993; 121: 1153–1163
   PubMed Web of Science ®Google Scholar
• Peruzzi B., Bottaro D.P. Targeting the c-Met signaling pathway in cancer. Clin. Cancer Res. 2006; 12: 3657–3660
   PubMed Web of Science ®Google Scholar
• Schwall R.H., Chang L.Y., Godowski P.J., Kahn D.W., Hillan K.J., Bauer K.D., Zioncheck T.F. Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth factor antagonists. NK1 and NK2. J. Cell Biol. 1996; 133: 709–718
   PubMed Web of Science ®Google Scholar
• Kemp L.E., Mulloy B., Gherardi E. Signalling by HGF/SF and Met: the role of heparan sulphate co-receptors. Biochem. Soc. Trans. 2006; 34: 414–417
   PubMed Web of Science ®Google Scholar
• Annes J.P., Chen Y., Munger J.S., Rifkin D.B. Integrin alphaVbeta6-mediated activation of latent TGF-beta requires the latent TGF-beta binding protein-1. J. Cell Biol. 2004; 165: 723–734
   PubMed Web of Science ®Google Scholar
• Chaudhry S.S., Cain S.A., Morgan A., Dallas S.L., Shuttleworth C.A., Kielty C.M. Fibrillin-1 regulates the bioavailability of TGFbeta1. J. Cell Biol. 2007; 176: 355–367
   PubMed Web of Science ®Google Scholar
• Ten Dijke P., Arthur H.M. Extracellular control of TGFbeta signalling in vascular development and disease. Nat. Rev. Mol. Cell Biol. 2007; 8: 857–868
   PubMed Web of Science ®Google Scholar
• Porter A.C., Vaillancourt R.R. Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis. Oncogene 1998; 17: 1343–1352
   PubMed Web of Science ®Google Scholar
• Faivre S., Djelloul S., Raymond E. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors. Sem. Oncol. 2006; 33: 407–420
   PubMed Web of Science ®Google Scholar
• Zwick E., Bange J., Ullrich A. Receptor tyrosine kinases as targets for anticancer drugs. Trends Mol. Med. 2002; 8: 17–23
   PubMed Web of Science ®Google Scholar